- Douglas G Altman, professor of statistics in medicine (d.altman@icrf.icnet.uk)a,
- Per Kragh Andersen, professor of biostatisticsb
- a Imperial Cancer Research Group Medical Statistics Group, Centre for Statistics in Medicine, Institute of Health Sciences, Headington, Oxford OX3 7LF
- b Department of Biostatistics, University of Copenhagen, DK-2200 Copenhagen N, Denmark
- Correspondence to: Correspondence to: D G Altman
- Accepted 5 July 1999
The number of patients who need to be treated to prevent one additional event (number needed to treat; NNT) has become a widely used measure of treatment benefit derived from the results of randomised controlled trials with a binary outcome 1 2 We show how to obtain a number needed to treat for studies where the primary outcome is the time to an event. We consider primarily the situation where there is no access to raw data, for example, when reviewing a published study, and also how to proceed when given the raw data.
Summary points
The number needed to treat is the number of patients who need to be treated to prevent one additional adverse outcome
This number (with confidence interval) is a clinically useful way to report the results of controlled trials
For any trial which has reported a binary outcome, the number needed to treat can be obtained as the reciprocal of the absolute difference in proportions of patients with the outcome of interest
In studies where the outcome of interest is the time to an event, calculations can be extended to show the number needed to treat at any time after the start of treatment
Time to event data
As noted previously, for studies with binary outcome the number needed to treat will vary according to the length of follow up.3 For studies of survival this relation with time is more explicit. There is no single number needed to treat; rather it can be calculated at any time point after the start of treatment. Often there are one or two time points of particular clinical interest.
A time specific number needed to treat represents the number of patients who need to be given the treatment in question for one additional patient to survive to that time point—that is, to benefit from …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: How much of a social media profile can doctors have?
Published 13 February 2012
Re: Diagnosis and management of Raynaud’s phenomenon
Published 13 February 2012
Re: Is it unethical for doctors to encourage healthy adults to donate a kidney to a stranger? No
Published 13 February 2012
Re: Report predicts 20 million AIDS orphans in Africa by 2010
Published 13 February 2012
Re: On the impossibility of being expert
Published 13 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012